학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 20건 | 목록 1~20
Academic Journal
Perelini OM; Auckland Regional Cancer and Blood Service, Te Toka Tumai Auckland, Health New Zealand, Te Whatu Ora, Auckland, New Zealand.; Nosa VH; University of Auckland, Auckland, New Zealand.; Wilson MK; Auckland Regional Cancer and Blood Service, Te Toka Tumai Auckland, Health New Zealand, Te Whatu Ora, Auckland, New Zealand.; University of Auckland, Auckland, New Zealand.; Lawrence NJ; Auckland Regional Cancer and Blood Service, Te Toka Tumai Auckland, Health New Zealand, Te Whatu Ora, Auckland, New Zealand.; University of Auckland, Auckland, New Zealand.; McNeill RB; University of Auckland, Auckland, New Zealand.; Wilson S; Auckland Regional Cancer and Blood Service, Te Toka Tumai Auckland, Health New Zealand, Te Whatu Ora, Auckland, New Zealand.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE
Madariaga A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.; Bhat G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Wilson MK; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Li X; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Cyriac S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Bowering V; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Hunt W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Gutierrez D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Bonilla L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Kasherman L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; McMullen M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Wang L; University of Toronto, Toronto, Ontario, Canada; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Ghai S; University of Toronto, Toronto, Ontario, Canada; Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.; Dhani NC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address: stephanie.lheureux@uhn.ca.
Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
So YJ; Medical Oncology, Auckland District Health Board (DHB), Auckland.; Jameson M; Waikato DHB, Waikato Clinical Campus, University of Auckland, Auckland.; Newton V; Northland DHB, Whangarei.; O'Donnell A; Capital and Coast DHB, Wellington.; Jeffery M; Canterbury DHB, Canterbury.; Jackson C; Southern DHB; Dunedin School of Medicine, University of Otago, Dunedin.; Tuck A; Medical Oncology, Auckland District Health Board (DHB), Auckland.; Gregory K; Nelson and Marlborough DHB, Nelson.; North R; Bay of Plenty DHB, Bay of Plenty.; Anderson M; Mid Central DHB.; Sharples K; Medical Oncology, Auckland District Health Board (DHB), Auckland; Cancer Trials New Zealand, University of Auckland, Auckland.; Findlay M; Medical Oncology, Auckland District Health Board (DHB), Auckland; Cancer Trials New Zealand, University of Auckland, Auckland.; Wilson MK; Medical Oncology, Auckland District Health Board (DHB), Auckland; Cancer Trials New Zealand, University of Auckland, Auckland.
Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet ISSN: 1175-8716 (Electronic) Linking ISSN: 00288446 NLM ISO Abbreviation: N Z Med J Subsets: MEDLINE
Academic Journal
Monk BJ; GOG Foundation, HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ.; Parkinson C; Medical Oncology, Addenbrooke's Hospital, Cambridge, United Kingdom.; Lim MC; Gynecologic Oncology, National Cancer Center Korea, Goyang-si, Gyeonggi-do, South Korea.; O'Malley DM; Division of Gynecologic Oncology, The Ohio State University, James Cancer Center, Columbus, OH.; Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Wilson MK; Department of Cancer and Blood, Auckland City Hospital, Auckland, New Zealand.; Coleman RL; US Oncology Research, The Woodlands, TX.; Lorusso D; MITO and Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS and Catholic University of Sacred Heart, Rome, Italy.; Bessette P; Department of Obstetrics and Gynecology, University of Sherbrooke, Sherbrooke, Quebec, Canada.; Ghamande S; Department of Obstetrics and Gynecology, Augusta University, Augusta, GA.; Christopoulou A; Medical Oncology, St Andrews General Hospital, Patras, Greece.; Provencher D; Princess Margaret Consortium and Department of Obstetrics-Gynaecology, Centre Hospitalier de l'Université de Montréal (CHUM), Institut du Cancer de Montréal, Montréal, Canada.; Prendergast E; Gynecologic Oncology, Minnesota Oncology and Metro-Minnesota Community Oncology Research Consortium, Minneapolis, MN.; Demirkiran F; Gynecologic Oncology Department, Medical Faculty, Istanbul University, Cerrahpaşa, Istanbul, Turkey.; Mikheeva O; Limited Liability Company MedPomosch, Saint Petersburg, Russia.; Yeku O; Gynecologic Cancers Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Chudecka-Glaz A; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.; Schenker M; Department of Medical Oncology, Sfantul Nectarie Oncology Center, Dolj, Romania.; Littell RD; Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA.; Safra T; Oncology Department, Tel Aviv Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Chou HH; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital (Linkou), Tao-Yuan, Taiwan.; College of Life Science, National Tsing Hua University, Hsinchu, Taiwan.; Morgan MA; Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia, PA.; Drochýtek V; Department of Obstetrics and Gynaecology, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic.; Barlin JN; Women's Cancer Care Associates, Division of Gynecologic Oncology, Albany Medical College, Albany, NY.; Van Gorp T; Division of Gynaecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Ueland F; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, University of Kentucky, Lexington, KY.; Lindahl G; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark.; Department of Oncology, Linköping University, Linköping, Sweden.; Anderson C; Department of Gynecologic Oncology, Willamette Valley Cancer Institute and Research Center, Eugene, OR.; Collins DC; Cancer Trials Ireland and Department of Medical Oncology, Cork University Hospital, Cork, Ireland.; Moore K; Stevenson Cancer Center at the University of Oklahoma Health Sciences Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Marme F; AGO and Department Obstetrics and Gynecology, University Hospital Mannheim, Mannheim, Germany.; Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.; McNeish IA; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Shih D; Clinical Operations, Clovis Oncology Inc, Boulder, CO.; Lin KK; Molecular Diagnostics, Clovis Oncology Inc, Boulder, CO.; Goble S; Biostatistics, Clovis Oncology Inc, Boulder, CO.; Hume S; Clinical Development, Clovis Oncology Inc, Boulder, CO.; Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.; Kristeleit RS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Wilson MK; Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand miwilson@adhb.govt.nz.; Friedlander ML; Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia.; Joly F; Department of Medical Oncology, Centre Francois Baclesse, Universite Basse Normandie, INSERM U1086, Caen, France.; Oza AM; Princess Margaret Cancer Centre, Toronto, Canada.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Madariaga A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada; Autonomous University of Barcelona, Barcelona, Spain.; Bhat G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Wilson MK; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Li X; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Cyriac S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Bowering V; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Hunt W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Gutierrez D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Bonilla L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Kasherman L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; McMullen M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Wang L; University of Toronto, Toronto, Ontario, Canada; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Ghai S; University of Toronto, Toronto, Ontario, Canada; Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.; Dhani NC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.; Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address: stephanie.lheureux@uhn.ca.
Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE
Editorial & Opinion
Wilson MK; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Karakasis K; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Oza AM; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Mweempwa A; Cancer and Blood, Auckland City Hospital, Auckland 1023, New Zealand.; Wilson MK; Cancer and Blood, Auckland City Hospital, Auckland 1023, New Zealand.
Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Academic Journal
Wilson MK; Department of Cancer and Blood, Auckland City Hospital, Auckland, New Zealand. miwilson@adhb.govt.nz.; Mercieca-Bebber R; NHMRC Clinical Trials Centre, The University of Sydney, NSW, Australia.; Friedlander M; Prince of Wales Cancer Centre, Sydney, NSW, Australia.
Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-0399 (Electronic) Linking ISSN: 20050380 NLM ISO Abbreviation: J Gynecol Oncol Subsets: MEDLINE
Academic Journal
Wilson MK; Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston, Canada.; Friedlander MLLheureux SSmall W JrPoveda APujade-Lauraine EKarakasis KBacon MBowering VChawla TOza AM
Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Academic Journal
Wilson MK; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Canada; Department of Medical Oncology, Auckland City Hospital, New Zealand.; Fong P; Department of Medical Oncology, Auckland City Hospital, New Zealand.; Mesnage S; Department of Medical Oncology, Auckland City Hospital, New Zealand.; Chrystal K; Department of Medical Oncology, Auckland City Hospital, New Zealand.; Shelling A; Faculty of Medical and Health Sciences, University of Auckland, New Zealand.; Payne K; Department of Pathology, Auckland City Hospital, New Zealand.; Mackay H; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Canada.; Wang L; Department of Statistics, Princess Margaret Cancer Centre, Canada.; Laframboise S; Department of Surgical Oncology, Princess Margaret Cancer Centre, Canada.; Rouzbahman M; Department of Pathology, Princess Margaret Cancer Centre, Canada.; Levin W; Department of Radiation Oncology, Princess Margaret Cancer Centre, Canada.; Oza AM; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Canada. Electronic address: amit.oza@uhn.ca.
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Academic Journal
Diaz-Padilla I; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Wilson MK; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Clarke BA; Department of Laboratory Medicine, University of Toronto, Toronto, Canada.; Hirte HW; Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Welch SA; Division of Medical Oncology, London Regional Cancer Program, London, Ontario, Canada.; Mackay HJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Biagi JJ; Department of Oncology, Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada.; Reedijk M; Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada.; Weberpals JI; Division of Gynecologic Oncology, The Ottawa Hospital, Ottawa, Ontario, Canada.; Fleming GF; The University of Chicago Medical Center, Chicago, IL, USA.; Wang L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Zhou C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Blattler C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Ivy SP; National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, Rockville, MD, USA.; Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address: amit.oza@uhn.ca.
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Editorial & Opinion
Lheureux S; Division of Medical Oncology and Haematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Wilson MK; Division of Medical Oncology and Haematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; O'Malley M; Department of Medical Imaging, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Sinaei M; Department of Medical Imaging, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Oza AM; Division of Medical Oncology and Haematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address: amit.oza@uhn.ca.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Wilson, Michelle K
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어